An interventional study of initial psycho-oncological contact and Standard in Cancer and Psycho-Oncology, sponsored by Lindenhofgruppe AG. Recruiting at 5 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by Lindenhofgruppe AG · Not applicable, Interventional, and Supportive care
When diagnosed with cancer, patients or their relatives may, if they wish, on the recommendation of the treatment team and/or in cases of high stress, seek psycho-oncological support.
This study investigates whether an initial consultation with a psycho-oncological specialist reduces anxiety and depression, improves quality of life, and whether patients subsequently make greater use of support services.
Participants will be randomised, meaning they will be assigned to groups at random to ensure that the results are comparable. In the intervention group, participants will receive a detailed initial consultation with a psycho-oncology specialist and standard treatment. In the control group, participants receive standard treatment. To gather results, questionnaires are administered at regular intervals (at the start, after 3 and 6 months). The study lasts a total of 6 months.
The study was developed by patients. It is being conducted simultaneously at several hospitals.
Exclusion Criteria:
Participants in the Intervention Arm will be contacted by a psycho-oncological counsellor. The study intervention is a 45 minutes initial psycho-oncological counselling and 3 months follow-up contact.
Other: initial psycho-oncological contact
Participants in the Control Arm will receive current standard of care psycho- oncological support according to local processes.
Other: Standard
initial psycho-oncological contact and 3 months follow-up contact
current standard of care psycho-oncological support according to local processes
Change in anxiety and depression
Change in anxiety and depression from study entry to the 6 months follow-up survey, measured using a summary measure of the entire HADS
Time frame: 6 months follow-up
Change in anxiety and depression components
Change in anxiety and depression components, from study entry to the 6 months follow-up survey, measured using the HADS subscales anxiety / depression
Time frame: 6 months follow-up
Change in quality of life
Change in quality of life, from study entry to the 6 months follow-up survey, measured using a summary measure of the entire EORTC QLQ C30
Time frame: 6 months follow-up
Change in quality-of-life components
Change in quality-of-life components, from study entry to the 6 months follow-up survey, measured using the EORTC QLQ C30 subscales global / functional / symptoms
Time frame: 6 months follow-up
Change in patient's global distress
Change in patient's global distress, from study entry to the 6 months follow-up survey, measured using the distress thermometer
Time frame: 6 months follow-up
Use of psycho-oncological support
Use of psycho-oncological support, measured as quantity of psycho oncological support from study entry to 6 months follow-up
Time frame: 6 months follow-up
Reasons for seeking or not seeking psycho-oncological support
Reasons for seeking or not seeking psycho-oncological support
Time frame: 6 months follow-up
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lindenhofgruppe AG